TRIP13 and colitis: Mechanistically, TNFR2 signaling elevated TRIP13 expression, which stabilized HAT1 protein by preventing UBE4A-mediated polyubiquitination degradation of HAT1, thus promoting Treg proliferation and protecting against colitis.